The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
- 13 September 2012
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 63 (3), 506-516
- https://doi.org/10.1016/j.eururo.2012.09.006
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind StudyThe Journal of Sexual Medicine, 2012
- Signalling pathways involved in sildenafil‐induced relaxation of human bladder dome smooth muscleBritish Journal of Pharmacology, 2010
- Changes in afferent activity after spinal cord injuryNeurourology and Urodynamics, 2009
- Spontaneous Contractions Evoke Afferent Nerve Firing in Mouse Bladders With Detrusor OveractivityJournal of Urology, 2009
- Nitric Oxide–Mediated Suppression of Detrusor Overactivity by Arginase Inhibitor in Rats with Chronic Spinal Cord InjuryUrology, 2008
- The neural control of micturitionNature Reviews Neuroscience, 2008
- Long‐term nitric oxide deficiency causes muscarinic supersensitivity and reduces β3‐adrenoceptor‐mediated relaxation, causing rat detrusor overactivityBritish Journal of Pharmacology, 2008
- Role of gap junctions in spontaneous activity of the rat bladderAmerican Journal of Physiology-Renal Physiology, 2007
- Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tractLife Sciences, 2007
- Neurokinins enhance excitability in capsaicin-responsive DRG neuronsExperimental Neurology, 2007